NasdaqCM - Nasdaq Real Time Price USD
Entero Therapeutics, Inc. (ENTO)
0.4159
-0.0021
(-0.50%)
As of 1:41:00 PM EDT. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BORKOWSKI EDWARD J Director | Stock Award(Grant) | Jan 2, 2024 | 20,248 |
| CASAMENTO CHARLES J Director | Stock Award(Grant) | Jan 2, 2024 | 19,937 |
| COELHO MARY THERESA Director | Stock Award(Grant) | Jan 2, 2024 | 20,237 |
| KHOSLA CHAITAN S Director | Stock Award(Grant) | Jun 11, 2024 | 25,329 |
| RIDDELL ALASTAIR Director | Stock Award(Grant) | Jan 2, 2024 | 20,240 |
| ROMANO SARAH M. Chief Financial Officer | Sale | Jan 6, 2025 | 17,287 |
| SAPIRSTEIN JAMES E Chief Executive Officer | Sale | Jul 2, 2024 | 35,816 |
| SYAGE JACK PH.D. President | Stock Award(Grant) | Mar 13, 2024 | -- |
Related Tickers
MTVA MetaVia Inc.
0.6700
+0.46%
PCSA Processa Pharmaceuticals, Inc.
0.2260
-3.42%
NBY NovaBay Pharmaceuticals, Inc.
0.5866
-1.41%
BXRXQ Baudax Bio, Inc.
0.0000
0.00%
ASBP Aspire Biopharma Holdings, Inc.
0.2357
-1.73%
TNFA TNF Pharmaceuticals, Inc.
0.1967
-10.79%
OGEN Oragenics, Inc.
0.1886
-3.67%
REVB Revelation Biosciences, Inc.
3.0653
-2.38%
TOVX Theriva Biologics, Inc.
0.5300
-6.56%
PBLA Panbela Therapeutics, Inc.
0.3000
+19.95%